secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-12-20T23:59:59+00:00
Accession:  0001607062-21-000626
Event type: debt
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma pays down $1.02M of convertible notes, principal now $1.34M
---------------------------------------------------------------------------

- Principal indebtedness on convertible notes reduced from $2,364,075 (Jun 30) to $1,340,621 (Dec 13, 2021).
- Company satisfied $1,023,454 of principal debt between July 1 and Dec 13, 2021.
- This represents a 43% reduction in principal debt over approximately 5.5 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000626/0001607062-21-000626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000626/rgbp122021form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer